These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 8069307)

  • 21. An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene.
    Quan F; Zonana J; Gunter K; Peterson KL; Magenis RE; Popovich BW
    Am J Hum Genet; 1995 May; 56(5):1042-51. PubMed ID: 7726157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene.
    Petek E; Kroisel PM; Schuster M; Zierler H; Wagner K
    Am J Med Genet; 1999 May; 84(3):229-32. PubMed ID: 10331598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal phenotype in two brothers with a full FMR1 mutation.
    Smeets HJ; Smits AP; Verheij CE; Theelen JP; Willemsen R; van de Burgt I; Hoogeveen AT; Oosterwijk JC; Oostra BA
    Hum Mol Genet; 1995 Nov; 4(11):2103-8. PubMed ID: 8589687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal model for fragile X syndrome.
    Oostra BA; Hoogeveen AT
    Ann Med; 1997 Dec; 29(6):563-7. PubMed ID: 9562525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
    Sharma D; Gupta M; Thelma BK
    Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile X syndrome and deletions in FMR1: new case and review of the literature.
    Hammond LS; Macias MM; Tarleton JC; Shashidhar Pai G
    Am J Med Genet; 1997 Nov; 72(4):430-4. PubMed ID: 9375726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families.
    Milà M; Kruyer H; Glover G; Sánchez A; Carbonell P; Castellví-Bell S; Volpini V; Rossell J; Gabarrón J; López I
    Hum Genet; 1994 Oct; 94(4):395-400. PubMed ID: 7927336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent and unexpected segregation of the FMR1 CGG repeat in a family with fragile X syndrome.
    Mornet E; Chateau C; Taillandier A; Simon-Bouy B; Serre JL
    Hum Genet; 1996 Apr; 97(4):512-5. PubMed ID: 8834253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures.
    Weisman-Shomer P; Cohen E; Fry M
    Nucleic Acids Res; 2000 Apr; 28(7):1535-41. PubMed ID: 10710419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent regression of the CGG repeat in FMR1 to an allele of normal size.
    Vits L; De Boulle K; Reyniers E; Handig I; Darby JK; Oostra B; Willems PJ
    Hum Genet; 1994 Nov; 94(5):523-6. PubMed ID: 7959688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.
    Lugenbeel KA; Peier AM; Carson NL; Chudley AE; Nelson DL
    Nat Genet; 1995 Aug; 10(4):483-5. PubMed ID: 7670500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.
    Eichler EE; Macpherson JN; Murray A; Jacobs PA; Chakravarti A; Nelson DL
    Hum Mol Genet; 1996 Mar; 5(3):319-30. PubMed ID: 8852655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes.
    van den Ouweland AM; Deelen WH; Kunst CB; Uzielli ML; Nelson DL; Warren ST; Oostra BA; Halley DJ
    Hum Mol Genet; 1994 Oct; 3(10):1823-7. PubMed ID: 7849707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
    Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
    Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome.
    Chiurazzi P; de Graaff E; Ng J; Verkerk AJ; Wolfson S; Fisch GS; Kozak L; Neri G; Oostra BA
    Am J Med Genet; 1994 Jul; 51(4):309-14. PubMed ID: 7942992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.
    Burman RW; Yates PA; Green LD; Jacky PB; Turker MS; Popovich BW
    Am J Hum Genet; 1999 Nov; 65(5):1375-86. PubMed ID: 10521303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mosaicism for an FMR1 gene deletion in a fragile X female.
    Fan H; Booker JK; McCandless SE; Shashi V; Fleming A; Farber RA
    Am J Med Genet A; 2005 Jul; 136(2):214-7. PubMed ID: 15940701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.